Other Species / Isoforms
  NEK7 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5
___MDEQsQGMQGPP
0 4
NEK7 (human) ___MDEQsQGMQGPP S5
NEK7 (mouse) ___MDEQSQGMQGPP S5
NEK7 (rat) ___MDEQPQGMQGPP P5
T30
RPDMGYNtLANFRIE
0 1
NEK7 (human) RPDMGYNtLANFRIE T30
NEK7 (mouse) RPDMGYNTLANFRIE T30
NEK7 (rat) RPDMGYNTLANFRIE T30
Y97
NHPNVIKyYASFIED
Downstream
1 0
Effects on Modified Protein
  • enzymatic activity, inhibited
  • protein conformation
Effects on Biological Processes:
  • apoptosis, altered
NEK7 (human) NHPNVIKyYASFIED Y97
NEK7 (mouse) NHPNVIKYYASFIED Y97
NEK7 (rat) NHPNVIKYYASFIED Y97
S147
KYFVQLCsALEHMHS
0 1
NEK7 (human) KYFVQLCsALEHMHS S147
NEK7 (mouse) KYFVQLCSALDHMHS S147
NEK7 (rat) KYFVQLCSALDHMHS S147
S187
LGLGRFFssKttAAH
Upstream
0 8
Treatment
  • ischemia
  • thymidine
NEK7 (human) LGLGRFFssKttAAH S187
NEK7 (mouse) LGLGRFFssKttAAH S187
NEK7 (rat) LGLGRFFSSKTTAAH S187
S188
GLGRFFssKttAAHs
Upstream
0 14
Treatment
  • ischemia
  • thymidine
NEK7 (human) GLGRFFssKttAAHs S188
NEK7 (mouse) GLGRFFssKttAAHs S188
NEK7 (rat) GLGRFFSSKTTAAHs S188
T190
GRFFssKttAAHsLV
Upstream
0 6
Treatment
  • angiotensin_2
  • thymidine
NEK7 (human) GRFFssKttAAHsLV T190
NEK7 (mouse) GRFFssKttAAHsLV T190
NEK7 (rat) GRFFSSKTTAAHsLV T190
T191
RFFssKttAAHsLVG
0 7
NEK7 (human) RFFssKttAAHsLVG T191
NEK7 (mouse) RFFssKttAAHsLVG T191
NEK7 (rat) RFFSSKTTAAHsLVG T191
S195
sKttAAHsLVGtPYY
Upstream
2 90
Kinase, in vitro:
  • NEK9 (human)
Treatment
  • BI2536
  • ischemia
  • thymidine
NEK7 (human) sKttAAHsLVGtPYY S195
NEK7 (mouse) sKttAAHsLVGTPYY S195
NEK7 (rat) SKTTAAHsLVGTPYY S195
T199
AAHsLVGtPYYMsPE
0 19
NEK7 (human) AAHsLVGtPYYMsPE T199
NEK7 (mouse) AAHsLVGTPYYMSPE T199
NEK7 (rat) AAHsLVGTPYYMSPE T199
S204
VGtPYYMsPERIHEN
Upstream
Downstream
1 7
Effects on Modified Protein
  • molecular association, regulation
Putative in vivo kinases:
  • PLK4 (human)
Regulatory protein:
  • SPATA2 (human)
Treatment
  • Centrinone
  • LPS
  • nocodazole
  • siRNA
  • thymidine
NEK7 (human) VGtPYYMsPERIHEN S204
NEK7 (mouse) VGTPYYMSPERIHEN S204
NEK7 (rat) VGTPYYMSPERIHEN S204
Y244
YGDKMNLysLCKKIE
0 124
NEK7 (human) YGDKMNLysLCKKIE Y244
NEK7 (mouse) YGDKMNLYSLCKKIE Y244
NEK7 (rat) YGDKMNLYSLCKKIE Y244
S245
GDKMNLysLCKKIEQ
0 1
NEK7 (human) GDKMNLysLCKKIEQ S245
NEK7 (mouse) GDKMNLYSLCKKIEQ S245
NEK7 (rat) GDKMNLYSLCKKIEQ S245
T286
PEKRPDVtyVyDVAK
0 2
NEK7 (human) PEKRPDVtyVyDVAK T286
NEK7 (mouse) PEKRPDIAYVYDVAK A286
NEK7 (rat) PEKRPDIAYVYDVAK A286
Y287
EKRPDVtyVyDVAKR
0 2
NEK7 (human) EKRPDVtyVyDVAKR Y287
NEK7 (mouse) EKRPDIAYVYDVAKR Y287
NEK7 (rat) EKRPDIAYVYDVAKR Y287
Y289
RPDVtyVyDVAKRMH
0 4
NEK7 (human) RPDVtyVyDVAKRMH Y289
NEK7 (mouse) RPDIAYVYDVAKRMH Y289
NEK7 (rat) RPDIAYVYDVAKRMH Y289